By-health Co. Stock Hits Day High with Strong Intraday Performance

By-health Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen a notable increase of 3.21% on July 21, 2026, reaching an intraday high of CNY 10.80. This surge comes amid a backdrop of mixed financial performance indicators. The company reported a net profit of CNY 401.27 million for the first nine months, reflecting a significant growth rate of 89.31%. Additionally, raw material costs have decreased by 4.8% year-over-year, contributing positively to its financial health. By-health Co. holds a robust cash position, with cash and equivalents at CNY 12,265.47 million, which supports its operational stability. Despite these positive developments, the company has faced challenges in long-term growth, with net sales declining at an annual rate of 1.34% and operating profit down by 14.45% over the past five years. The stock has generated a return of -17.98% over the past year, underperforming against the China Shanghai Composite index consistently for the last three years. With a price-to-book ratio of 0.92 and a return on equity of 5.95%, By-health Co. continues to navigate a complex market landscape.